Longitudinal Changes of NF-κB Downstream Mediators and Peritoneal Transport Characteristics in Incident Peritoneal Dialysis Patients

Sci Rep. 2020 Apr 15;10(1):6440. doi: 10.1038/s41598-020-63258-3.

Abstract

The role of intra-peritoneal mediators in the regulation peritoneal transport is not completely understood. We investigate the relation between longitudinal changes in dialysis effluent level of nuclear factor kappa-B (NF-κB) downstream mediators and the change in peritoneal transport over 1 year. We studied 46 incident PD patients. Their peritoneal transport characteristics were determined after starting PD and then one year later. Concomitant dialysis effluent levels of interleukin-6 (IL-6), cyclo-oxygenase-2 (COX-2) and hepatocyte growth factor (HGF) are determined. There were significant correlations between baseline and one-year dialysis effluent IL-6 and COX-2 levels with the corresponding dialysate-to-plasma creatinine level at 4 hours (D/P4) and mass transfer area coefficient of creatinine (MTAC). After one year, patients who had peritonitis had higher dialysis effluent IL-6 (26.6 ± 17.4 vs 15.1 ± 12.3 pg/ml, p = 0.037) and COX-2 levels (4.97 ± 6.25 vs 1.60 ± 1.53 ng/ml, p = 0.007) than those without peritonitis, and the number of peritonitis episode significantly correlated with the IL-6 and COX-2 levels after one year. In contrast, dialysis effluent HGF level did not correlate with peritoneal transport. There was no difference in any mediator level between patients receiving conventional and low glucose degradation product solutions. Dialysis effluent IL-6 and COX-2 levels correlate with the concomitant D/P4 and MTAC of creatinine. IL-6 and COX-2 may contribute to the short-term regulation of peritoneal transport.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Creatinine / analysis
  • Creatinine / metabolism
  • Cyclooxygenase 2 / analysis
  • Cyclooxygenase 2 / metabolism
  • Dialysis Solutions / analysis*
  • Dialysis Solutions / metabolism
  • Female
  • Follow-Up Studies
  • Hepatocyte Growth Factor / analysis
  • Hepatocyte Growth Factor / metabolism
  • Humans
  • Interleukin-6 / analysis
  • Interleukin-6 / metabolism
  • Kidney Failure, Chronic / therapy
  • Longitudinal Studies
  • Male
  • Middle Aged
  • NF-kappa B / metabolism*
  • Peritoneal Dialysis / adverse effects*
  • Peritoneum / metabolism*
  • Peritoneum / physiopathology
  • Peritonitis / epidemiology*
  • Peritonitis / etiology
  • Peritonitis / physiopathology

Substances

  • Dialysis Solutions
  • HGF protein, human
  • IL6 protein, human
  • Interleukin-6
  • NF-kappa B
  • Hepatocyte Growth Factor
  • Creatinine
  • Cyclooxygenase 2
  • PTGS2 protein, human